v3.26.1
Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock Series C [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 0 $ 52 [1] $ 94,122,702 $ (89,428,436) $ 4,694,320
Beginning balance, shares at Dec. 31, 2024 0 51,653      
Issuance of common shares, net of costs $ 10 [1] 672,785 672,795
Issuance of common shares, net of costs, shares   10,253      
Series B preferred stock converted to common stock $ 2 [1] (139,012) (139,010)
Series B preferred stock converted to common stock, shares   2,163      
Offering costs [1] (55,120) (55,120)
Share-based compensation [1] 76,906 76,906
Issuance of restricted stock units 0 $ 0 [1] (0) 0 0
Issuance of restricted stock units, shares   25      
Capitalized dividends 0 $ 0 [1] 58,758 (58,758) 0
Capitalized dividends converted to common stock $ 2 [1] 139,574 139,576
Capitalized dividends converted to common stock, shares   2,163      
Net loss [1] (1,752,565) (1,752,565)
Ending balance, value at Mar. 31, 2025 $ 0 $ 66 [1] 94,876,593 (91,239,759) 3,636,902
Ending balance, shares at Mar. 31, 2025 0 66,257      
Beginning balance, value at Dec. 31, 2024 $ 0 $ 52 [1] 94,122,702 (89,428,436) 4,694,320
Beginning balance, shares at Dec. 31, 2024 0 51,653      
Net loss         (3,321,218)
Ending balance, value at Jun. 30, 2025 $ 1 $ 85 [1] 95,724,582 (92,852,762) 2,871,907
Ending balance, shares at Jun. 30, 2025 750 85,060      
Beginning balance, value at Dec. 31, 2024 $ 0 $ 52 [1] 94,122,702 (89,428,436) 4,694,320
Beginning balance, shares at Dec. 31, 2024 0 51,653      
Ending balance, value at Dec. 31, 2025 $ 1 $ 403 [1] 101,518,433 (97,283,343) 4,235,494
Ending balance, shares at Dec. 31, 2025 750 402,833      
Beginning balance, value at Mar. 31, 2025 $ 0 $ 66 [1] 94,876,593 (91,239,759) 3,636,902
Beginning balance, shares at Mar. 31, 2025 0 66,257      
Issuance of common shares, net of costs $ 3 [1] 82,497   82,500
Issuance of common shares, net of costs, shares   3,247      
Issuance of Series C preferred stock and warrants, net of issuance costs $ 1 [1] 699,999 700,000
Issuance of Series C preferred stock and warrants, net of issuance costs, shares 750        
Series B preferred stock converted to common stock $ 0 $ 16 [1] (15) 0 0
Series B preferred stock converted to common stock, shares   15,552      
Share-based compensation [1] 21,158 21,158
Capitalized dividends 0 0 [1] 44,350 (44,350) 0
RSS adjustment 0 $ 0 [1] 0 0 0
RSS adjustment, shares   4      
Net loss [1] (1,568,653) (1,568,653)
Ending balance, value at Jun. 30, 2025 $ 1 $ 85 [1] 95,724,582 (92,852,762) 2,871,907
Ending balance, shares at Jun. 30, 2025 750 85,060      
Beginning balance, value at Dec. 31, 2025 $ 1 $ 403 [1] 101,518,433 (97,283,343) 4,235,494
Beginning balance, shares at Dec. 31, 2025 750 402,833      
Issuance of common shares, net of costs $ 98 [1] 891,825 891,923
Issuance of common shares, net of costs, shares   98,043      
Offering costs [1] (23,387) (23,387)
Share-based compensation [1] 14,897 14,897
Capitalized dividends 0 0 [1] 30,323 (30,323) 0
RSS adjustment 0 $ 0 [1] 0 0 0
RSS adjustment, shares   38      
Net loss [1] (2,281,553) (2,281,553)
Ending balance, value at Mar. 31, 2026 $ 1 $ 501 [1] 102,432,091 (99,595,219) 2,837,374
Ending balance, shares at Mar. 31, 2026 750 500,914      
Beginning balance, value at Dec. 31, 2025 $ 1 $ 403 [1] 101,518,433 (97,283,343) 4,235,494
Beginning balance, shares at Dec. 31, 2025 750 402,833      
Net loss         (5,256,819)
Ending balance, value at Jun. 30, 2026 $ 0 $ 5,803 [1] 113,254,051 (102,570,485) 10,689,369
Ending balance, shares at Jun. 30, 2026 0 5,803,182      
Beginning balance, value at Mar. 31, 2026 $ 1 $ 501 [1] 102,432,091 (99,595,219) 2,837,374
Beginning balance, shares at Mar. 31, 2026 750 500,914      
Issuance of common shares, net of costs $ 1,405 [1] 2,180,317 2,181,722
Issuance of common shares, net of costs, shares   1,405,006      
Issuance of Pre-Funded Warrants [1] 5,711,457 5,711,457
Common Warrant [1] 4,106,814 4,106,814
Offering costs [1] (1,190,179) (1,190,179)
Exercise of Pre-Funded Warrants into Common Stock 0 $ 3,680 [1] (3,680) 0 0
Exercise of Pre-Funded Warrants into Common Stock, shares   3,679,737      
Share-based compensation [1] 15,087 15,087
Series C Preferred Conversion $ (1) $ 192 [1] (191) 0 0
Series C Preferred Conversion, shares (750) 191,815      
Exercise of Common Warrants $ 1 [1] 2,359 2,360
Exercise of Common Warrants, shares   1,000      
Capitalized dividends converted to common stock 0 $ 24 [1] (24) 0 0
Capitalized dividends converted to common stock, shares   24,710      
Net loss [1] (2,975,266) (2,975,266)
Ending balance, value at Jun. 30, 2026 $ 0 $ 5,803 [1] $ 113,254,051 $ (102,570,485) $ 10,689,369
Ending balance, shares at Jun. 30, 2026 0 5,803,182      
[1] The Company’s common stock outstanding as of June 30, 2026 and 2025 and December 31, 2025 and 2024 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.